SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-039890
Filing Date
2010-04-29
Accepted
2010-04-29 06:00:53
Documents
7
Period of Report
2010-06-11
Effectiveness Date
2010-04-29

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A c99086def14a.htm DEF 14A 640655
3 GRAPHIC c99086p9908601.jpg GRAPHIC 9291
4 GRAPHIC c99086c9908604.gif GRAPHIC 8816
5 GRAPHIC c99086c9908601.gif GRAPHIC 19761
6 GRAPHIC c99086c9908602.gif GRAPHIC 953
7 GRAPHIC c99086c9908603.gif GRAPHIC 970
8 filename8.htm COVER 3944
  Complete submission text file 0000950123-10-039890.txt   701807
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 10778669
SIC: 2836 Biological Products, (No Diagnostic Substances)